Japan· JP-1190407G2020
フレマネズマブ（遺伝子組換え）
A medicinal product containing フレマネズマブ（遺伝子組換え）, registered in Japan by 大塚製薬, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- フレマネズマブ（遺伝子組換え）
- Manufacturer
- 大塚製薬
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
フレマネズマブ（遺伝子組換え） in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAJOVYTeva GmbH, Ulm
- United StatesAJOVYTeva Pharmaceuticals USA, Inc.
- SwitzerlandAjovy
- FinlandAJOVYTeva GmbH
- United KingdomAjovy 225mg/1.5ml solution for injection pre-filled pensTeva UK Ltd
- BelgiumAjovy 225 mgTeva
- CanadaAJOVYTEVA CANADA LIMITED
- SpainAJOVY 225 MG SOLUCION INYECTABLE EN JERINGA PRECARGADATeva Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Ajovy
- Iceland · Ajovy
- Liechtenstein · Ajovy
- Norway · Ajovy
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fe3e65d2-cd87-487d-b190-0fbefa9845ce GET /v1/drugs/fe3e65d2-cd87-487d-b190-0fbefa9845ce?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "２２５ｍｇ１．５ｍＬ１キット",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "1190407G2020",
"category": "注射薬",
"price_yen": 38856,
"generic_name": "フレマネズマブ（遺伝子組換え）",
"product_name_jp": null,
"therapeutic_class": "1190",
"transitional_expiry": null
}See everything about フレマネズマブ（遺伝子組換え）.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.